Matt Devalaraja
Impact in
- Nephrology top 10%
- Dialysis and Renal Disease Management
-
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- Dialysis and Renal Disease Management 2
-
- Erythropoietin and Anemia Treatment 2
- Co-authors
- Larry Lo (5 shared papers)Michael Davidson (3 shared papers)Pablo E. Pérgola (2 shared papers)Douglas Kling (2 shared papers)Florian M.M. Baeres (1 shared paper)Mads D.M. Engelmann (1 shared paper)Milana Ivkovic (1 shared paper)Paul M. Ridker (1 shared paper)
- Journals
- Journal of the American Society of Nephrology (1 paper)Inflammatory Bowel Diseases (1 paper)The Lancet (1 paper)Journal of the American Heart Association (1 paper)Nephrology Dialysis Transplantation (1 paper)
- Partner nations
- United StatesItalyUnited Kingdom
In The Last Decade
Matt Devalaraja
7 papers receiving 582 citations
Matt Devalaraja's Hit Papers
Peers
Comparison fields: 5 of 64
- Nephrology 53
- Immunology 157
- Hematology 70
- Cardiology and Cardiovascular Medicine 110
- Genetics 33
Countries citing papers authored by Matt Devalaraja
This map shows the geographic impact of Matt Devalaraja's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matt Devalaraja with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matt Devalaraja more than expected).
Fields of papers citing papers by Matt Devalaraja
This network shows the impact of papers produced by Matt Devalaraja. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matt Devalaraja. The network helps show where Matt Devalaraja may publish in the future.
Co-authors
The 25 scholars most cited alongside Matt Devalaraja, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial Hit paper breakdown → | 2021 | 475 |
| 2 | 2020 | 58 | |
| 3 | 2019 | 21 | |
| 4 | 2015 | 18 | |
| 5 | 2020 | 9 | |
| 6 | 2022 | 7 | |
| 7 | 2023 | 2 | |
| 8 | 2019 | 0 |
About Matt Devalaraja
Matt Devalaraja is a scholar working on Nephrology, Hematology, Molecular Biology, Dermatology and Cardiology and Cardiovascular Medicine, having authored 8 papers that have together received 590 indexed citations. Recurring topics across this work include Erythropoietin and Anemia Treatment (2 papers), Dialysis and Renal Disease Management (2 papers), Gut microbiota and health (1 paper), Allergic Rhinitis and Sensitization (1 paper), Sodium Intake and Health (1 paper), Digestive system and related health (1 paper), Asthma and respiratory diseases (1 paper) and Probiotics and Fermented Foods (1 paper). The work is most often cited by research in Nephrology (53 citations), Immunology (157 citations), Hematology (70 citations), Cardiology and Cardiovascular Medicine (110 citations) and Genetics (33 citations). Matt Devalaraja has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Larry Lo, Michael Davidson, Pablo E. Pérgola, Douglas Kling, Florian M.M. Baeres, Mads D.M. Engelmann, Milana Ivkovic, Paul M. Ridker, Peter Libby and G. Kees Hovingh. Their work appears in journals such as Journal of the American Society of Nephrology, Inflammatory Bowel Diseases, The Lancet, Journal of the American Heart Association and Nephrology Dialysis Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.